HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR
Hyperimmune IgG and/or IgM compositions and method for preparing thereof and method for obtaining hyperimmune human plasma from a donor. A liquid therapeutic hyperimmune globulin composition including human plasma-derived immunoglobulin G (IgG) having antibody titre between 250 and 2,500 per mg/mL o...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
13.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hyperimmune IgG and/or IgM compositions and method for preparing thereof and method for obtaining hyperimmune human plasma from a donor. A liquid therapeutic hyperimmune globulin composition including human plasma-derived immunoglobulin G (IgG) having antibody titre between 250 and 2,500 per mg/mL of IgG and/or a SARS-CoV-2 neutralization activity (IC50 neutralization titer) between 1.5 and 15 per mg/mL of IgG for use in the treatment of coronavirus disease 2019 (COVID-19) in a patient in need thereof. A liquid therapeutic or prophylactic hyperimmune immunoglobulin composition including human plasma-derived immunoglobulin M (IgM) having a SARS-CoV-2 titre between 2,000 and 17,000 and/or a SARS-CoV-2 neutralization activity (IC50 neutralization titre) between 200 and 70,000, methods for preparing thereof, and the use thereof for the treatment or prophylaxis of COVID-19. A method for obtaining hyperimmune human plasma from a donor for use in the treatment of COVID-19. |
---|---|
AbstractList | Hyperimmune IgG and/or IgM compositions and method for preparing thereof and method for obtaining hyperimmune human plasma from a donor. A liquid therapeutic hyperimmune globulin composition including human plasma-derived immunoglobulin G (IgG) having antibody titre between 250 and 2,500 per mg/mL of IgG and/or a SARS-CoV-2 neutralization activity (IC50 neutralization titer) between 1.5 and 15 per mg/mL of IgG for use in the treatment of coronavirus disease 2019 (COVID-19) in a patient in need thereof. A liquid therapeutic or prophylactic hyperimmune immunoglobulin composition including human plasma-derived immunoglobulin M (IgM) having a SARS-CoV-2 titre between 2,000 and 17,000 and/or a SARS-CoV-2 neutralization activity (IC50 neutralization titre) between 200 and 70,000, methods for preparing thereof, and the use thereof for the treatment or prophylaxis of COVID-19. A method for obtaining hyperimmune human plasma from a donor for use in the treatment of COVID-19. |
Author | GAJARDO RODRÍGUEZ, Rodrigo VANDEBERG, Peter LINDSAY, Myles ROMES, Erin ORLOVA, Natalia ROSA-BRAY, Marilyn WELLHOUSE, Andrea JOSE, Marta AUGER, Charles |
Author_xml | – fullname: ROSA-BRAY, Marilyn – fullname: AUGER, Charles – fullname: ORLOVA, Natalia – fullname: ROMES, Erin – fullname: VANDEBERG, Peter – fullname: GAJARDO RODRÍGUEZ, Rodrigo – fullname: LINDSAY, Myles – fullname: WELLHOUSE, Andrea – fullname: JOSE, Marta |
BookMark | eNqNjb0KwjAUhTvo4N87XHAW7Q_oem2TJmByQ5IOTqVInKQt1HfwtW3BQZyczuF8H5xlNGu7Niyil7gaZqVSlWYgyxJQF3uyY1WQkzLkpJek3bSDYl5QAXzkxjKDVuoSvGCWEf8V6OxR6kn4fhCVQg3mgk4hcEsKEArSZNfR_N48hrD55CracuZzsQt9V4ehb26hDc-6cskhSZP4dMwyjNP_rDeTWECa |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2023218744A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2023218744A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:49:59 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2023218744A13 |
Notes | Application Number: US202118000380 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230713&DB=EPODOC&CC=US&NR=2023218744A1 |
ParticipantIDs | epo_espacenet_US2023218744A1 |
PublicationCentury | 2000 |
PublicationDate | 20230713 |
PublicationDateYYYYMMDD | 2023-07-13 |
PublicationDate_xml | – month: 07 year: 2023 text: 20230713 day: 13 |
PublicationDecade | 2020 |
PublicationYear | 2023 |
RelatedCompanies | GRIFOLS WORLDWIDE OPERATIONS LIMITED |
RelatedCompanies_xml | – name: GRIFOLS WORLDWIDE OPERATIONS LIMITED |
Score | 3.4814453 |
Snippet | Hyperimmune IgG and/or IgM compositions and method for preparing thereof and method for obtaining hyperimmune human plasma from a donor. A liquid therapeutic... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230713&DB=EPODOC&locale=&CC=US&NR=2023218744A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivqmU3E6JaD0rWzZulofhmRNu05MUvoh82msXQuCdMNV_BP8t72UTYcPe8sXCXfhl8td7i4I3SUgk4iVW3p_ZuU6INHUH-bmXM_g7CN5d0ZmuTLoc2F6sfE06U9q6H0TC1PlCf2qkiMColLAe1md18s_IxarfCtX7eQNmhaPbjRg2lo7Vl7NpKex4cDxJZO2ZtuDONREUPV11f9zBgVdaQ8u0vcKD87LUMWlLLeFinuM9n2YryhPUC0rGujQ3vy91kAHfP3kDcU1-lan6Nt79UHv4jwWDh6PRpgK1pYBFDm2JfdlOK6CglU75k7kSYZBycPAZZ8qrwcceU7gSPf_ADmM6FioAdsreDGnAvvPNOQUu4HkmGImhQzO0K3rRLanA0XTXwZO43Cb_N45qheLIrtAuJOQlHRSs2vAvSmxTCs1jHmuMuBbfdg2s4lau2a63N19hY5UVVlCSa-F6uXHZ3YNIrxMbirO_wDid5OF |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivqmU_FjakDpW9m6dbU-DMmadq0uSemHzKexdi0I0g1X8U_w3_ZSNh0-7C3kQkISfne5y30gdJeATNLM3FR7UzNXAYmG-jAzZmoGvE_LO1NtmkuDPuOGG-tP4964ht7XsTBVntCvKjkiICoFvJcVv178GbFo5Vu5bCVv0DV_dKI-VVbasfRq1roKHfRtX1BhKZbVj0OFBxWtI-vP6QR0pR14ZN9LPNgvAxmXstgUKs4h2vVhvqI8QrWsaKB9a117rYH22OrLG5or9C2P0bf76oPexVjMbewNh5hw2hIBNBm2BPNF6FVBwbIfMztyBcWg5GE4ZZ9IrwccuXZgC-f_ADGIiMflgM0V3JgRjv0RCRnBTiAYJpgKLoITdOvYkeWqsKPJ7wFO4nBz-91TVC_mRXaGcDvRUq2dGh0d3k2JaZiprs9ymQHf7MG1GeeouW2mi-3kG7TvRmw0GXn8-RIdSJK0imrdJqqXH5_ZFYjzMrmubuEH-9yWeA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HYPERIMMUNE+IGG+AND%2FOR+IGM+COMPOSITIONS+AND+METHOD+FOR+PREPARING+THEREOF+AND+METHOD+FOR+OBTAINING+HYPERIMMUNE+HUMAN+PLASMA+FROM+A+DONOR&rft.inventor=ROSA-BRAY%2C+Marilyn&rft.inventor=AUGER%2C+Charles&rft.inventor=ORLOVA%2C+Natalia&rft.inventor=ROMES%2C+Erin&rft.inventor=VANDEBERG%2C+Peter&rft.inventor=GAJARDO+RODR%C3%8DGUEZ%2C+Rodrigo&rft.inventor=LINDSAY%2C+Myles&rft.inventor=WELLHOUSE%2C+Andrea&rft.inventor=JOSE%2C+Marta&rft.date=2023-07-13&rft.externalDBID=A1&rft.externalDocID=US2023218744A1 |